News | News By Subject | News by Disease News By Date | Search News

Disease News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Investors Relieved as Seattle Genetics (SGEN) Pulls Out Win for Phase III Lymphoma Trial     6/26/2017
Genentech (RHHBY)'s Hemophilia Blockbuster Contender Hits Phase III Goals, But Questions Remain     6/26/2017
Bay Area's Portola (PTLA) Rockets as the FDA Approves First and Only Anticoagulant for Hospitals     6/26/2017
Matinas BioPharma (MTNB) Tanks as Lead Drug Fails to Match Standard-Of-Care Treatment in Phase II Infection Trial     6/26/2017
SoCal's Neothetics (NEOT) Craters as Fat-Reduction Drug Flunks Phase II Study     6/26/2017
Meet the 'Rock Star of Science' Obsessed With Stopping Alzheimer's     6/23/2017
bluebird bio (BLUE) Touts Impressive Data From Late-Stage Gene Therapy Study     6/23/2017
FDA Calls Cara Therapeutics (CARA)' Kidney Disease Drug a Breakthrough, Stock Soars     6/23/2017
Seattle Genetics (SGEN) Takes Another Hit as the FDA Slaps Hold on IND for Vadastuximab Talirine     6/22/2017
BIO2017: BIO Urges Biotech Leaders to Get Active on Legislation     6/22/2017
More Deaths Lead Seattle Genetics (SGEN) to Discontinue Phase III Leukemia Study     6/21/2017
Clovis Oncology (CLVS) Stock Soars as Ovarian Cancer Trial Dazzles     6/21/2017
BIO2017: Eli Lilly (LLY) Clinical Development Head Looks to Innovate, Continue Alzheimer’s Research     6/21/2017
Novartis AG (NVS)'s Next-Generation Eye Drug Works With Fewer Injections Than Rivals     6/21/2017
BIO2017: Former UK Prime Minister Cameron Calls for More Alzheimer’s Research     6/21/2017

News from Around the Web
Experts Discover 3 Things That Can Protect The Brain From Alzheimer's, National Academies of Sciences, Engineering, and Medicine Study Reveals     6/26/2017
The FDA Has Never Approved A Drug Like This In Its 111-Year History     6/26/2017
Abbott (ABT) Warns Doctors on Potential Communication Issue With Heartmate 3 Pump     6/26/2017
Plant Problems Lead The FDA To Reject Pfizer (PFE)'s Epogen Biosimilar Again     6/23/2017
Why This Small Biotech With A Single Drug In Human Trials Might Be A Big Winner     6/22/2017
Artificial Intelligence Helps Improve MRI Imaging Of Strokes, MIT Study Reveals     6/22/2017
Vanda (VNDA): Several Catalysts Coming Up     6/21/2017
Alzheimer's Drug Leads UBS To Upgrade Biogen (BIIB)     6/21/2017
Neuron Transistor Behaves Like A Brain Neuron, Nanyang Technological University Study Reveals     6/21/2017
3 Must-Covet Cancer Biotech Stocks     6/20/2017
How Upcoming Mystic Data Will Be AstraZeneca PLC (AZN) CEO's Biggest Test     6/20/2017
How Microsoft's HoloLens Can Reduce The Time You Are On The Operating Table     6/20/2017
While Amgen (AMGN)-Size Biotechs Run Into Trouble, These Are The Biotechs With The Most Promising Pipelines     6/19/2017
New Three-In-One Blood Test Opens Door To Precision Medicine For Prostate Cancer, The Institute of Cancer Research Study Reveals     6/19/2017
Alzheimer's Affects Twice As Many People As Estimated, And The Numbers Are Climbing, USC Alzheimer's Therapeutic Research Institute (ATRI) Study Reveals     6/16/2017

Press Releases
CSL Behring Release: FDA Approves HAEGARDA (C1 Esterase Inhibitor Subcutaneous [Human]), First And Only Subcutaneous Preventive Treatment For Hereditary Angioedema     6/26/2017
The New England Journal of Medicine Publishes Full Analysis Of Rydapt (Midostaurin) Phase III RATIFY Trial In Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML)     6/26/2017
European Hematology Association: Early Metabolic Response Determination By FDG-PET Allows Substantial Reduction Of Chemotherapy And Its Toxicity In Patients With Advanced Stage Hodgkin Lymphoma: The GHSG HD18 Study     6/26/2017
European Hematology Association: Clinical And Biologic Covariates Of Outcomes In ZUMA-1: A Pivotal Trial Of Axicabtagene Ciloleucel (Axi-Cel; KTE-C19) In Patients With Refractory Aggressive Non-Hodgkin Lymphoma (NHL)     6/26/2017
European Hematology Association: Global Trial Of The Efficacy And Safety Of CTL019 In Adult Patients With Relapsed Or Refractory Diffuse Large B-Cell Lymphoma: An Interim Analysis Of The JULIET Study     6/26/2017
European Hematology Association: Multicenter Open-Label Phase 2 Study Of Ibrutinib In Chronic Graft Versus Host Disease (cGVHD) After Failure Of Corticosteroids     6/26/2017
NewVac Presented Results Of Quisinostat's Phase II Clinical Trial At ASCO 2017     6/26/2017
Semnur Announces Successful Phase I/II Trial In Patients With Radicular Pain For Its Lead Product, SP-102     6/26/2017
Genentech (RHHBY)’s Emicizumab Showed Positive Results In Phase III Studies (HAVEN 1 And HAVEN 2) In Hemophilia A With Inhibitors     6/26/2017
Onconova (ONTX) Presents Rigosertib Data At The 22nd Congress Of The European Hematology Association In Madrid     6/26/2017
Innovation Pharma (Formerly known as Cellceutix) (CTIX) Completes Treatments In Phase II PoC Trial For Induction Of Remission In Inflammatory Bowel Disease; Topline Results With Endoscopic Response To Be Presented July 13, 2017     6/26/2017
ImmunoGen (IMGN) Presents Data From Phase I Study Of IMGN779 In Acute Myeloid Leukemia     6/26/2017
Zosano (ZSAN) Announces Outcome Of End Of Phase II Meetings With FDA     6/26/2017
Clarus Therapeutics Re-Submits JATENZO NDA Following Positive Results Of inTUne Trial     6/26/2017
AMAG (AMAG) Announces U.S. FDA Filing Acceptance Of Supplemental New Drug Application For Makena® (Hydroxyprogesterone Caproate Injection) Subcutaneous Auto-Injector     6/26/2017